The Ramachandran Lab develops innovative and novel diagnostic assays for neuroinflammatory conditions. Their work aims to improve patient care through cost-effective CSF testing, particularly benefiting low-resource settings.
They are a translational laboratory bridging clinical medicine and scientific innovation to develop novel diagnostic tools for neuroinflammatory conditions. Their research aims to understand the underlying mechanisms and pathology of these disorders through advanced technologies. They utilise metagenomic next-generation sequencing, targeted pathogen enrichment, host transcriptomics, aneuploidy detection, and phage immunoprecipitation sequencing to create comprehensive diagnostic solutions. Their integrated approach combines cutting-edge molecular techniques with clinical expertise to advance patient care and improve diagnostic outcomes.
